Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective binding to ATP sites in protein kinases, making it valuable in targeted therapies for tumors. Commonly employed in pharmaceutical research to optimize drug candidates for improved potency and selectivity. Also utilized in the preparation of small molecule inhibitors for inflammatory and neurological disorders due to its favorable binding properties and modifiability.